TLDR past the first bit of nonsense.
ATL has been testing our product and has negotiated a USD$5M investment in the company.
They have clearly had direct access to the company and have undoubtedly asked detailed questions relating to progress and issues with the plant.
Assuming otherwise is ridiculous, imo.
The same would apply to companies that are in discussion regarding strategic investment for the expansion; they would have access to the company for detailed enquiry and discussion about all manner of things relating to the product and plant development.
Have you ever signed NDA’s with companies and discussed their business in detail? Didn’t think so.
hmmm…let’s see:
Layman’s pessimism-bias-driven speculation and flaky “analysis”
vs
World-class battery company testing our product and providing a strategic investment of USD$5M.
Stating/suggesting/implying that ATL don’t know any more about the company, our product and our operations than what has been published via the ASX is just more absolute nonsense.
These types of engagements effectively always involve NDAs and access to more information than is publicly available.
Provide something - anything - that suggests there is anything atypical in this case.
Hollow guesses don’t count.
- Forums
- ASX - By Stock
- General Discussion AGY
TLDR past the first bit of nonsense. ATL has been testing our...
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AGY (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.5¢ |
Change
-0.008(8.60%) |
Mkt cap ! $125.2M |
Open | High | Low | Value | Volume |
9.0¢ | 9.3¢ | 8.5¢ | $336.2K | 3.778M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 588247 | 8.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.6¢ | 165066 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 603175 | 0.085 |
4 | 219873 | 0.084 |
3 | 157062 | 0.083 |
3 | 336585 | 0.082 |
2 | 114691 | 0.081 |
Price($) | Vol. | No. |
---|---|---|
0.086 | 168713 | 5 |
0.087 | 44843 | 3 |
0.088 | 232558 | 1 |
0.089 | 69615 | 2 |
0.090 | 91167 | 2 |
Last trade - 15.48pm 15/07/2024 (20 minute delay) ? |
Featured News
AGY (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online